SlideShare a Scribd company logo
Antigen
From Wikipedia,the free encyclopedia
Jumpto navigationJumptosearch
An illustrationthatshowshowantigensinducethe immunesystemresponse byinteractingwithan
antibodythatmatchesthe molecularstructure of an antigen
In immunology,an antigen(Ag) isamolecule ormolecularstructure oranyforeignparticulate matteror
a pollengrainthatcan bindto a specificantibodyorT-cell receptor.[1] The presence of antigensinthe
bodymay triggeran immune response.[2] The termantigenoriginallyreferredtoa substance thatisan
antibodygenerator.[3] Antigenscanbe proteins,peptides(aminoacidchains),polysaccharides(chains
of monosaccharides/simple sugars),lipids,ornucleicacids.[4]
Antigensare recognizedbyantigenreceptors, includingantibodiesandT-cell receptors.Diverse antigen
receptorsare made by cellsof the immune systemsothateach cell hasa specificityforasingle antigen.
Upon exposure toanantigen,onlythe lymphocytesthatrecognize thatantigenare activatedand
expanded,aprocessknownasclonal selection.[4] Inmostcases,an antibodycanonlyreact to and bind
one specificantigen;insome instances,however,antibodiesmaycross-reactandbindmore thanone
antigen.
The antigenmayoriginate fromwithinthe body("self-protein") orfromthe external environment
("non-self").[2] The immune systemidentifiesandattacks"non-self"external antigensandusuallydoes
not react to self-proteindue tonegative selectionof Tcellsinthe thymusandB cellsin the bone
marrow.[5]
Vaccinesare examplesof antigensinanimmunogenicform, whichare intentionallyadministeredtoa
recipienttoinduce the memoryfunctionof the adaptiveimmunesystemtowardsantigensof the
pathogeninvadingthatrecipient.The vaccine forseasonal influenzaisacommon example.[6]
Contents
1 Etymology
2 Terminology
3 Sources
3.1 Exogenousantigens
3.2 Endogenousantigens
3.3 Autoantigens
3.4 Neoantigens
3.4.1 Viral antigens
3.4.2 Tumor antigens
3.4.2.1 Process
3.5 Nativity
4 Antigenicspecificity
5 See also
6 References
Etymology
Paul Ehrlichcoinedthe termantibody(inGermanAntikörper) inhisside-chaintheoryatthe endof the
19th century.[7] In1899, LadislasDeutsch(LászlóDetre) namedthe hypothetical substanceshalfway
betweenbacterialconstituentsandantibodies"substancesimmunogènesouantigènes"(antigenicor
immunogenicsubstances).He originallybelievedthosesubstancestobe precursorsof antibodies,justas
zymogenisa precursorof an enzyme.But,by1903, he understoodthatan antigeninducesthe
productionof immune bodies(antibodies)andwrote thatthe wordantigenisa contractionof
antisomatogen(Immunkörperbildner).The OxfordEnglishDictionaryindicatesthatthe logical
constructionshouldbe "anti(body)-gen".[8]
Terminology
Epitope – the distinctsurface featuresof anantigen,itsantigenicdeterminant.
Antigenicmolecules,normally"large"biological polymers,usuallypresentsurface featuresthatcanact
as pointsof interactionforspecificantibodies.Anysuchfeature constitutesanepitope.Mostantigens
have the potential tobe boundbymultiple antibodies,eachof whichisspecifictoone of the antigen's
epitopes.Usingthe "lockandkey"metaphor,the antigencanbe seenasa stringof keys(epitopes) each
of whichmatchesa differentlock(antibody).Differentantibodyidiotypes,eachhave distinctlyformed
complementarity-determiningregions.
Allergen –A substance capable of causingan allergicreaction.The (detrimental)reactionmayresult
afterexposure viaingestion,inhalation,injection,orcontactwithskin.
Superantigen –A class of antigensthatcause non-specificactivationof T-cells,resultinginpolyclonal T-
cell activationandmassive cytokinerelease.
Tolerogen –A substance thatinvokesaspecificimmune non-responsivenessdue toitsmolecularform.
If its molecularformischanged,atolerogencanbecome animmunogen.
Immunoglobulin-bindingprotein –ProteinssuchasproteinA,proteinG,and proteinLthat are capable
of bindingtoantibodiesatpositionsoutside of the antigen-bindingsite.While antigensare the "target"
of antibodies,immunoglobulin-bindingproteins"attack"antibodies.
T-dependentantigen –Antigensthatrequirethe assistance of Tcellstoinduce the formationof specific
antibodies.
T-independentantigen –Antigensthatstimulate Bcellsdirectly.
Immunodominantantigens –Antigensthatdominate (overall othersfromapathogen) intheirabilityto
produce an immune response.Tcell responsestypicallyare directedagainstarelativelyfew
immunodominantepitopes,althoughinsome cases(e.g.,infectionwiththe malariapathogen
Plasmodiumspp.) itisdispersedoverarelativelylarge numberof parasite antigens.[9]
Antigen-presentingcellspresentantigensinthe formof peptidesonhistocompatibilitymolecules.The T
cellsselectivelyrecognize the antigens;dependingonthe antigenandthe type of the histocompatibility
molecule,differenttypesof Tcellswill be activated.ForT-cell receptor(TCR) recognition,the peptide
mustbe processedintosmall fragmentsinside the cell andpresentedbyamajorhistocompatibility
complex (MHC).[10] The antigencannotelicitthe immuneresponse withoutthe helpof animmunologic
adjuvant.[11] Similarly,the adjuvantcomponentof vaccinesplaysanessentialrole inthe activationof
the innate immune system.[12][13]
An immunogenisanantigensubstance (oradduct) thatisable to triggera humoral (innate) orcell-
mediatedimmuneresponse.[14] Itfirstinitiatesaninnate immune response,whichthencausesthe
activationof the adaptive immune response.Anantigenbindsthe highlyvariable immunoreceptor
products(B-cell receptororT-cell receptor) once thesehave beengenerated.Immunogensare those
antigens, termedimmunogenic,capable of inducinganimmune response.[15]
At the molecularlevel,anantigencanbe characterizedbyitsabilitytobindtoan antibody'sparatopes.
Differentantibodieshave the potential todiscriminateamongspecificepitopespresentonthe antigen
surface.A haptenis a small moleculethatcan onlyinduce animmune responsewhenattachedtoa
largercarrier molecule,suchasa protein.Antigenscanbe proteins,polysaccharides,lipids,nucleicacids
or otherbiomolecules.[4] This includesparts(coats,capsules,cell walls,flagella,fimbriae,andtoxins) of
bacteria,viruses,andothermicroorganisms.Non-microbial non-self antigenscaninclude pollen,egg
white,andproteinsfromtransplantedtissuesandorgansor onthe surface of transfusedbloodcells.
Sources
Antigenscanbe classifiedaccordingtotheirsource.
Exogenousantigens
Exogenousantigensare antigensthathave enteredthe bodyfromthe outside,forexample,by
inhalation,ingestionorinjection.The immunesystem'sresponsetoexogenousantigensisoften
subclinical.Byendocytosisorphagocytosis,exogenousantigensare takenintothe antigen-presenting
cells(APCs) andprocessedintofragments.APCsthenpresentthe fragmentstoT helpercells(CD4+) by
the use of classII histocompatibilitymoleculesontheirsurface.SomeTcellsare specificforthe
peptide:MHCcomplex.Theybecome activatedandstartto secrete cytokines,substancesthatactivate
cytotoxicT lymphocytes(CTL),antibody-secretingBcells,macrophagesandotherparticles.
Some antigensstartout as exogenousandlaterbecome endogenous(forexample,intracellularviruses).
Intracellularantigenscanbe returnedtocirculationuponthe destructionof the infectedcell.
Endogenousantigens
Endogenousantigensare generatedwithinnormal cellsasa resultof normal cell metabolism, or
because of viral or intracellularbacterial infection.The fragmentsare thenpresentedonthe cell surface
inthe complex withMHCclassI molecules.If activatedcytotoxicCD8+T cellsrecognize them,the Tcells
secrete varioustoxinsthatcause the lysisorapoptosisof the infectedcell.Inordertokeepthe cytotoxic
cellsfromkillingcellsjustforpresentingself-proteins,the cytotoxiccells(self-reactive Tcells) are
deletedasaresultof tolerance (negativeselection).Endogenousantigensinclude xenogenic
(heterologous),autologousandidiotypicorallogenic(homologous) antigens.Sometimesantigensare
part of the hostitself inanautoimmune disease.[2]
Autoantigens
An autoantigenisusuallyaself-proteinorproteincomplex(andsometimesDNA orRNA) that is
recognizedbythe immune systemof patientssufferingfromaspecificautoimmune disease.Under
normal conditions,theseself-proteinsshouldnotbe the targetof the immune system,butin
autoimmune diseases,theirassociatedTcellsare notdeletedandinsteadattack.
Neoantigens
Neoantigensare those thatare entirelyabsentfromthe normal humangenome.Ascomparedwith
nonmutatedself-proteins,neoantigensare of relevance totumorcontrol,asthe qualityof the T cell
pool that isavailable forthese antigensisnotaffectedbycentral Tcell tolerance.Technologyto
systematicallyanalyzeTcell reactivityagainstneoantigensbecame available onlyrecently.[16]
Neoantigenscanbe directlydetectedandquantifiedthroughamethodcalledMANA-SRMdevelopedby
a moleculardiagnosticscompany,Complete OmicsInc.,throughcollaboratingwithateaminJohns
HopkinsUniversitySchool of Medicine.[17]
Viral antigens
For virus-associatedtumors,suchascervical cancerand a subsetof headand neckcancers, epitopes
derivedfromviral openreadingframescontribute tothe pool of neoantigens.[16]
Tumor antigens
Tumor antigensare those antigens thatare presentedbyMHCclass I or MHC classII moleculesonthe
surface of tumor cells.Antigensfoundonlyonsuchcellsare calledtumor-specificantigens(TSAs)and
generallyresultfromatumor-specificmutation.More commonare antigensthatare presentedby
tumor cellsandnormal cells,calledtumor-associatedantigens(TAAs).CytotoxicTlymphocytesthat
recognize these antigensmaybe able todestroytumorcells.[16]
Tumor antigenscanappearon the surface of the tumorin the formof, forexample,amutatedreceptor,
inwhichcase theyare recognizedbyB cells.[16]
For humantumorswithouta viral etiology,novel peptides(neo-epitopes) are createdbytumor-specific
DNA alterations.[16]
Process
A large fractionof humantumor mutationsiseffectivelypatient-specific.Therefore,neoantigensmay
alsobe basedonindividualtumorgenomes.Deep-sequencingtechnologiescanidentifymutations
withinthe protein-codingpartof the genome (the exome) andpredictpotential neoantigens.Inmice
models,forall novel proteinsequences,potential MHC-bindingpeptideswere predicted.The resulting
setof potential neoantigenswasusedtoassessTcell reactivity.Exome–basedanalyseswere exploited
ina clinical setting,toassessreactivityinpatientstreatedbyeithertumor-infiltratinglymphocyte (TIL)
cell therapyorcheckpointblockade.Neoantigenidentificationwassuccessfulformultiple experimental
model systemsandhumanmalignancies.[16]
The false-negativerate of cancerexome sequencingislow—i.e.:the majorityof neoantigensoccur
withinexonicsequence withsufficientcoverage.However,the vastmajorityof mutationswithin
expressedgenesdonotproduce neoantigensthatare recognizedbyautologousTcells.[16]
As of 2015 mass spectrometryresolutionisinsufficienttoexclude manyfalsepositivesfromthe pool of
peptidesthatmaybe presentedbyMHC molecules.Instead,algorithmsare usedtoidentifythe most
likelycandidates.Thesealgorithmsconsiderfactorssuchas the likelihoodof proteasomal processing,
transportintothe endoplasmicreticulum, affinityforthe relevantMHCclassI allelesandgene
expressionorproteintranslationlevels.[16]
The majorityof human neoantigensidentifiedinunbiasedscreensdisplayahighpredictedMHCbinding
affinity.Minorhistocompatibilityantigens,aconceptuallysimilarantigenclassare alsocorrectly
identifiedbyMHCbindingalgorithms.Anotherpotential filterexamineswhetherthe mutationis
expectedtoimprove MHCbinding.The nature of the central TCR-exposedresiduesof MHC-bound
peptidesisassociatedwithpeptide immunogenicity.[16]
Nativity
A native antigenisanantigenthatisnot yetprocessedbyan APCto smallerparts.T cellscannotbind
native antigens,butrequire thattheybe processedbyAPCs,whereasBcellscanbe activatedbynative
ones.
Antigenicspecificity
Antigenicspecificityisthe abilityof the hostcellstorecognize anantigenspecificallyasaunique
molecularentityanddistinguishitfromanotherwith exquisite precision.Antigenspecificityisdue
primarilytothe side-chainconformationsof the antigen.Itismeasurable andneednotbe linearorof a
rate-limitedsteporequation.[2][6] BothT cellsandB cellsare cellularcomponentsof adaptive
immunity.[2][4]
See also
Antigenicescape
Antitoxin
Conformational epitope
Epitope
Linearepitope
Magneticimmunoassay
Neutralizingantibody
Original antigenicsin
Paul Ehrlich:Magic Bullet
Polyclonal Bcell response
Priming(immunology)
References
"Antibody".NationalHumanGenome ResearchInstitute,USNational Institutesof Health.2020.
Retrieved13October2020.
"Immune systemanddisorders".MedlinePlus,USNational Institute of Medicine.28September2020.
Retrieved13October2020.
Male, DavidK.(2006). Immunology.ElsevierHealthSciences.p.10.ISBN 978-0323033992.
Abbas,Abul K.;Lichtman,Andrew;Pillai,Shiv(2018)."AntibodiesandAntigens".CellularandMolecular
Immunology(9thed.).Philadelphia:Elsevier.ISBN 978-0-323-52324-0.
Gallucci,S; Lolkema,M; Matzinger,P(November1999). "Natural adjuvants:endogenousactivatorsof
dendriticcells".NatureMedicine.5(11): 1249–55. doi:10.1038/15200. PMID 10545990. S2CID
29090284.
"Antigeniccharacterization".USCentersforDisease Control andPrevention.15October2019.
Retrieved13October2020.
Strebhardt,Klaus;Ullrich,Axel (Jun2008). "Paul Ehrlich'smagicbulletconcept:100 years of progress".
Nature ReviewsCancer.8(6): 473–80. doi:10.1038/nrc2394. ISSN 1474-1768. PMID 18469827. S2CID
30063909.
Lindenmann,Jean(1984)."Originof the Terms 'Antibody'and'Antigen'".Scand.J.Immunol.19(4):
281–85. doi:10.1111/j.1365-3083.1984.tb00931.x. PMID 6374880.
DoolanDL, SouthwoodS,FreilichDA,SidneyJ,GraberNL,ShatneyL,BebrisL, FlorensL,DobanoC,
WitneyAA,AppellaE,HoffmanSL,Yates JR,Carucci DJ, Sette A (August2003). "Identificationof
Plasmodiumfalciparumantigensbyantigenicanalysisof genomicandproteomicdata".Proceedingsof
the National Academyof Sciencesof the UnitedStatesof America.100 (17): 9952–57.
Bibcode:2003PNAS..100.9952D. doi:10.1073/pnas.1633254100. PMC 187898. PMID 12886016.
Parham,Peter.(2009). The Immune System, 3rdEdition,p.G:2, GarlandScience,TaylorandFrancis
Group, LLC.
Gavin,AL; Hoebe,K;Duong,B; Ota,T; Martin,C; Beutler,B;Nemazee,D(22 December2006).
"Adjuvant-enhancedantibodyresponsesinthe absence of toll-like receptorsignaling".Science.314
(5807): 1936–38. Bibcode:2006Sci...314.1936G. doi:10.1126/science.1135299. PMC 1868398. PMID
17185603.
JanewayCA,Jr (1 November2013). "Pillarsarticle:approachingthe asymptote?Evolutionand
revolutioninimmunology.Coldspringharbsympquantbiol.1989. 54: 1–13". Journal of Immunology.
191 (9):4475–87. PMID 24141854.
Gayed,PM (June 2011). "Towarda modernsynthesisof immunity:CharlesA.JanewayJr.andthe
immunologist'sdirtylittle secret".The Yale Journal of BiologyandMedicine.84(2):131–38. ISSN 1551-
4056. PMC 3117407. PMID 21698045.
Parham,Peter.(2009). The Immune System, 3rdEdition,p.G:11, Garland Science,TaylorandFrancis
Group, LLC.
KubyImmunology(6thed.).Macmillan.2006. p.77. ISBN 978-1-4292-0211-4.
Schumacher,Ton N.;Schreiber,RobertD.(April 3,2015). "Neoantigensincancerimmunotherapy".
Science.348 (6230): 69–74. Bibcode:2015Sci...348...69S. doi:10.1126/science.aaa4971. PMID 25838375.
Wang, Qing.;Douglass,Jacqueline (September16,2019). "Direct DetectionandQuantificationof
Neoantigens".CancerImmunol Res.7(11):1748–54. doi:10.1158/2326-6066.CIR-19-0107. PMC
6825591. PMID 31527070.
vte
Lymphocyticadaptive immunesystemandcomplement
Lymphoid
Antigens
AntigenSuperantigenAllergenAntigenicvariationHapten
Epitope LinearConformationalMimotope
Antigenpresentation/professionalAPCs:DendriticcellMacrophageBcellImmunogen
Antibodies
AntibodyMonoclonal antibodiesPolyclonal antibodiesAutoantibodyMicroantibodyPolyclonal Bcell
responseAllotypeIsotypeIdiotype
Immune complexParatope
Immunityvs.
tolerance
Action:ImmunityAutoimmunityAlloimmunityAllergyHypersensitivityInflammationCross-reactivityCo-
stimulation
Inaction:Tolerance CentralPeripheralClonal anergyClonal deletionTolerance in
pregnancyImmunodeficiencyImmune privilege
Immunogenetics
Affinity maturationSomatichypermutationClonalselectionV(D)JrecombinationJunctional
diversityImmunoglobulinclassswitchingMHC/HLA
Lymphocytes
CellularTcellHumoral BcellNKcell
Substances
CytokinesOpsoninCytolysin
Authoritycontrol:National librariesEdit thisatWikidata
France (data)UkraineGermanyIsraelUnitedStates
Categories:Immune systemBiomolecules
Navigationmenu
Notloggedin
Talk
Contributions
Create account
Log in
ArticleTalk
ReadEditViewhistory
Search
SearchWikipedia
Main page
Contents
Currentevents
Randomarticle
AboutWikipedia
Contact us
Donate
Contribute
Help
Learn to edit
Communityportal
Recentchanges
Uploadfile
Tools
What linkshere
Relatedchanges
Special pages
Permanentlink
Page information
Cite thispage
Wikidataitem
Print/export
DownloadasPDF
Printable version
In otherprojects
WikimediaCommons
Languages
‫ية‬ ‫عرب‬ ‫ال‬
Español
हिन्दी
Bahasa Indonesia
Bahasa Melayu
Português
Русский
‫و‬ ‫ارد‬
中文
59 more
Editlinks
Thispage waslasteditedon27 March 2022, at 06:42 (UTC).
Textisavailable underthe Creative CommonsAttribution-ShareAlike License 3.0;additional termsmay
apply.Byusingthissite,youagree to the Termsof Use and PrivacyPolicy.Wikipedia® isaregistered
trademarkof the WikimediaFoundation,Inc.,anon-profitorganization.
PrivacypolicyAboutWikipediaDisclaimersContactWikipediaMobile viewDevelopersStatisticsCookie
statementWikimediaFoundationPoweredbyMediaWiki

More Related Content

Similar to Antigen.docx

Antigen .pptx
Antigen .pptxAntigen .pptx
Antigen .pptx
vidhunmuringeri7
 
Introduction to antigen
Introduction to  antigenIntroduction to  antigen
Introduction to antigen
Amjad Afridi
 
Antigen lecture-51 (1)
Antigen lecture-51 (1)Antigen lecture-51 (1)
Antigen lecture-51 (1)
Naeem Ahmed
 
Antigen-Lecture-51 (1).ppt
Antigen-Lecture-51 (1).pptAntigen-Lecture-51 (1).ppt
Antigen-Lecture-51 (1).ppt
dipinbhandari
 
Autoimmunity and Tolerance
Autoimmunity and ToleranceAutoimmunity and Tolerance
Autoimmunity and Tolerance
Atifa Ambreen
 
Immunochemistry by dr.reena
Immunochemistry by dr.reenaImmunochemistry by dr.reena
Immunochemistry by dr.reena
Dr.reena singh
 
Immunological tolerance and mechanisms involved
Immunological tolerance and mechanisms involvedImmunological tolerance and mechanisms involved
Immunological tolerance and mechanisms involved
SallyElfishawi1
 
Immunomodulators screening methods
Immunomodulators screening methodsImmunomodulators screening methods
Immunomodulators screening methods
VIGNESHROSS
 
BASIC_IMMUNOLOGY_-_Copy.pptx
BASIC_IMMUNOLOGY_-_Copy.pptxBASIC_IMMUNOLOGY_-_Copy.pptx
BASIC_IMMUNOLOGY_-_Copy.pptx
malti19
 
BASIC_IMMUNOLOGY_-_Copy.pptx
BASIC_IMMUNOLOGY_-_Copy.pptxBASIC_IMMUNOLOGY_-_Copy.pptx
BASIC_IMMUNOLOGY_-_Copy.pptx
malti19
 
bacterial immunopathology
bacterial immunopathologybacterial immunopathology
bacterial immunopathologyPmn12345
 
Antigens notes
Antigens notes Antigens notes
Antigens notes
Vamsi kumar
 
No 13 immunological_tolerance
No 13 immunological_toleranceNo 13 immunological_tolerance
No 13 immunological_tolerancekhellagone
 
Antigen
AntigenAntigen
Antigen
MUKESH SINGH
 
Immunology
ImmunologyImmunology
Immunology
Ahmed Omara
 
Immunity-Tcell-Bcell-Cytokines
Immunity-Tcell-Bcell-CytokinesImmunity-Tcell-Bcell-Cytokines
Immunity-Tcell-Bcell-Cytokines
Chintan Patel
 
Immunity types and compliment system ppt
Immunity types and compliment system pptImmunity types and compliment system ppt
Immunity types and compliment system ppt
ali7070
 
Antigen
AntigenAntigen
Antigen
Abdur Rouf
 
Immunologic tolerance
Immunologic toleranceImmunologic tolerance
Immunologic toleranceRobin Gulati
 

Similar to Antigen.docx (20)

Antigen .pptx
Antigen .pptxAntigen .pptx
Antigen .pptx
 
Introduction to antigen
Introduction to  antigenIntroduction to  antigen
Introduction to antigen
 
Antigen lecture-51 (1)
Antigen lecture-51 (1)Antigen lecture-51 (1)
Antigen lecture-51 (1)
 
Antigen-Lecture-51 (1).ppt
Antigen-Lecture-51 (1).pptAntigen-Lecture-51 (1).ppt
Antigen-Lecture-51 (1).ppt
 
G.2014-immuno~ (2.antigen-lyj)
 G.2014-immuno~ (2.antigen-lyj) G.2014-immuno~ (2.antigen-lyj)
G.2014-immuno~ (2.antigen-lyj)
 
Autoimmunity and Tolerance
Autoimmunity and ToleranceAutoimmunity and Tolerance
Autoimmunity and Tolerance
 
Immunochemistry by dr.reena
Immunochemistry by dr.reenaImmunochemistry by dr.reena
Immunochemistry by dr.reena
 
Immunological tolerance and mechanisms involved
Immunological tolerance and mechanisms involvedImmunological tolerance and mechanisms involved
Immunological tolerance and mechanisms involved
 
Immunomodulators screening methods
Immunomodulators screening methodsImmunomodulators screening methods
Immunomodulators screening methods
 
BASIC_IMMUNOLOGY_-_Copy.pptx
BASIC_IMMUNOLOGY_-_Copy.pptxBASIC_IMMUNOLOGY_-_Copy.pptx
BASIC_IMMUNOLOGY_-_Copy.pptx
 
BASIC_IMMUNOLOGY_-_Copy.pptx
BASIC_IMMUNOLOGY_-_Copy.pptxBASIC_IMMUNOLOGY_-_Copy.pptx
BASIC_IMMUNOLOGY_-_Copy.pptx
 
bacterial immunopathology
bacterial immunopathologybacterial immunopathology
bacterial immunopathology
 
Antigens notes
Antigens notes Antigens notes
Antigens notes
 
No 13 immunological_tolerance
No 13 immunological_toleranceNo 13 immunological_tolerance
No 13 immunological_tolerance
 
Antigen
AntigenAntigen
Antigen
 
Immunology
ImmunologyImmunology
Immunology
 
Immunity-Tcell-Bcell-Cytokines
Immunity-Tcell-Bcell-CytokinesImmunity-Tcell-Bcell-Cytokines
Immunity-Tcell-Bcell-Cytokines
 
Immunity types and compliment system ppt
Immunity types and compliment system pptImmunity types and compliment system ppt
Immunity types and compliment system ppt
 
Antigen
AntigenAntigen
Antigen
 
Immunologic tolerance
Immunologic toleranceImmunologic tolerance
Immunologic tolerance
 

More from AngelDelacruz900577

ups.pptx
ups.pptxups.pptx
Teacher Binder by Slidesgo.pptx
Teacher Binder by Slidesgo.pptxTeacher Binder by Slidesgo.pptx
Teacher Binder by Slidesgo.pptx
AngelDelacruz900577
 
Economics Lesson for Pre-K by Slidesgo.pptx
Economics Lesson for Pre-K by Slidesgo.pptxEconomics Lesson for Pre-K by Slidesgo.pptx
Economics Lesson for Pre-K by Slidesgo.pptx
AngelDelacruz900577
 
printable-cute-greetings-cards-collection-for-elementary.pptx
printable-cute-greetings-cards-collection-for-elementary.pptxprintable-cute-greetings-cards-collection-for-elementary.pptx
printable-cute-greetings-cards-collection-for-elementary.pptx
AngelDelacruz900577
 
wizard-magical-birthday.pptx
wizard-magical-birthday.pptxwizard-magical-birthday.pptx
wizard-magical-birthday.pptx
AngelDelacruz900577
 
Reading Workshop by Slidesgo.pptx
Reading Workshop by Slidesgo.pptxReading Workshop by Slidesgo.pptx
Reading Workshop by Slidesgo.pptx
AngelDelacruz900577
 
Netflix template[159].pptx
Netflix template[159].pptxNetflix template[159].pptx
Netflix template[159].pptx
AngelDelacruz900577
 
gradient-timeline-infographics.pptx
gradient-timeline-infographics.pptxgradient-timeline-infographics.pptx
gradient-timeline-infographics.pptx
AngelDelacruz900577
 
Adaptive immune system.docx
Adaptive immune system.docxAdaptive immune system.docx
Adaptive immune system.docx
AngelDelacruz900577
 
Rare.docx
Rare.docxRare.docx
metalllic.docx
metalllic.docxmetalllic.docx
metalllic.docx
AngelDelacruz900577
 
Polythiazyl.docx
Polythiazyl.docxPolythiazyl.docx
Polythiazyl.docx
AngelDelacruz900577
 
nimale husbandry.docx
nimale husbandry.docxnimale husbandry.docx
nimale husbandry.docx
AngelDelacruz900577
 
Page protected with pending changes.docx
Page protected with pending changes.docxPage protected with pending changes.docx
Page protected with pending changes.docx
AngelDelacruz900577
 
Radioactive waste.docx
Radioactive waste.docxRadioactive waste.docx
Radioactive waste.docx
AngelDelacruz900577
 
Major histocompatibility complex.docx
Major histocompatibility complex.docxMajor histocompatibility complex.docx
Major histocompatibility complex.docx
AngelDelacruz900577
 
Electrical conductor.docx
Electrical conductor.docxElectrical conductor.docx
Electrical conductor.docx
AngelDelacruz900577
 
Lanthanide.docx
Lanthanide.docxLanthanide.docx
Lanthanide.docx
AngelDelacruz900577
 
climate change.docx
climate change.docxclimate change.docx
climate change.docx
AngelDelacruz900577
 

More from AngelDelacruz900577 (20)

ups.pptx
ups.pptxups.pptx
ups.pptx
 
Teacher Binder by Slidesgo.pptx
Teacher Binder by Slidesgo.pptxTeacher Binder by Slidesgo.pptx
Teacher Binder by Slidesgo.pptx
 
Economics Lesson for Pre-K by Slidesgo.pptx
Economics Lesson for Pre-K by Slidesgo.pptxEconomics Lesson for Pre-K by Slidesgo.pptx
Economics Lesson for Pre-K by Slidesgo.pptx
 
printable-cute-greetings-cards-collection-for-elementary.pptx
printable-cute-greetings-cards-collection-for-elementary.pptxprintable-cute-greetings-cards-collection-for-elementary.pptx
printable-cute-greetings-cards-collection-for-elementary.pptx
 
wizard-magical-birthday.pptx
wizard-magical-birthday.pptxwizard-magical-birthday.pptx
wizard-magical-birthday.pptx
 
Reading Workshop by Slidesgo.pptx
Reading Workshop by Slidesgo.pptxReading Workshop by Slidesgo.pptx
Reading Workshop by Slidesgo.pptx
 
Netflix template[159].pptx
Netflix template[159].pptxNetflix template[159].pptx
Netflix template[159].pptx
 
gradient-timeline-infographics.pptx
gradient-timeline-infographics.pptxgradient-timeline-infographics.pptx
gradient-timeline-infographics.pptx
 
Adaptive immune system.docx
Adaptive immune system.docxAdaptive immune system.docx
Adaptive immune system.docx
 
Rare.docx
Rare.docxRare.docx
Rare.docx
 
metalllic.docx
metalllic.docxmetalllic.docx
metalllic.docx
 
T.docx
T.docxT.docx
T.docx
 
Polythiazyl.docx
Polythiazyl.docxPolythiazyl.docx
Polythiazyl.docx
 
nimale husbandry.docx
nimale husbandry.docxnimale husbandry.docx
nimale husbandry.docx
 
Page protected with pending changes.docx
Page protected with pending changes.docxPage protected with pending changes.docx
Page protected with pending changes.docx
 
Radioactive waste.docx
Radioactive waste.docxRadioactive waste.docx
Radioactive waste.docx
 
Major histocompatibility complex.docx
Major histocompatibility complex.docxMajor histocompatibility complex.docx
Major histocompatibility complex.docx
 
Electrical conductor.docx
Electrical conductor.docxElectrical conductor.docx
Electrical conductor.docx
 
Lanthanide.docx
Lanthanide.docxLanthanide.docx
Lanthanide.docx
 
climate change.docx
climate change.docxclimate change.docx
climate change.docx
 

Recently uploaded

Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Marketing internship report file for MBA
Marketing internship report file for MBAMarketing internship report file for MBA
Marketing internship report file for MBA
gb193092
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 

Recently uploaded (20)

Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Marketing internship report file for MBA
Marketing internship report file for MBAMarketing internship report file for MBA
Marketing internship report file for MBA
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 

Antigen.docx

  • 1. Antigen From Wikipedia,the free encyclopedia Jumpto navigationJumptosearch An illustrationthatshowshowantigensinducethe immunesystemresponse byinteractingwithan antibodythatmatchesthe molecularstructure of an antigen In immunology,an antigen(Ag) isamolecule ormolecularstructure oranyforeignparticulate matteror a pollengrainthatcan bindto a specificantibodyorT-cell receptor.[1] The presence of antigensinthe bodymay triggeran immune response.[2] The termantigenoriginallyreferredtoa substance thatisan antibodygenerator.[3] Antigenscanbe proteins,peptides(aminoacidchains),polysaccharides(chains of monosaccharides/simple sugars),lipids,ornucleicacids.[4] Antigensare recognizedbyantigenreceptors, includingantibodiesandT-cell receptors.Diverse antigen receptorsare made by cellsof the immune systemsothateach cell hasa specificityforasingle antigen. Upon exposure toanantigen,onlythe lymphocytesthatrecognize thatantigenare activatedand expanded,aprocessknownasclonal selection.[4] Inmostcases,an antibodycanonlyreact to and bind one specificantigen;insome instances,however,antibodiesmaycross-reactandbindmore thanone antigen. The antigenmayoriginate fromwithinthe body("self-protein") orfromthe external environment ("non-self").[2] The immune systemidentifiesandattacks"non-self"external antigensandusuallydoes not react to self-proteindue tonegative selectionof Tcellsinthe thymusandB cellsin the bone marrow.[5] Vaccinesare examplesof antigensinanimmunogenicform, whichare intentionallyadministeredtoa recipienttoinduce the memoryfunctionof the adaptiveimmunesystemtowardsantigensof the pathogeninvadingthatrecipient.The vaccine forseasonal influenzaisacommon example.[6] Contents 1 Etymology 2 Terminology 3 Sources
  • 2. 3.1 Exogenousantigens 3.2 Endogenousantigens 3.3 Autoantigens 3.4 Neoantigens 3.4.1 Viral antigens 3.4.2 Tumor antigens 3.4.2.1 Process 3.5 Nativity 4 Antigenicspecificity 5 See also 6 References Etymology Paul Ehrlichcoinedthe termantibody(inGermanAntikörper) inhisside-chaintheoryatthe endof the 19th century.[7] In1899, LadislasDeutsch(LászlóDetre) namedthe hypothetical substanceshalfway betweenbacterialconstituentsandantibodies"substancesimmunogènesouantigènes"(antigenicor immunogenicsubstances).He originallybelievedthosesubstancestobe precursorsof antibodies,justas zymogenisa precursorof an enzyme.But,by1903, he understoodthatan antigeninducesthe productionof immune bodies(antibodies)andwrote thatthe wordantigenisa contractionof antisomatogen(Immunkörperbildner).The OxfordEnglishDictionaryindicatesthatthe logical constructionshouldbe "anti(body)-gen".[8] Terminology Epitope – the distinctsurface featuresof anantigen,itsantigenicdeterminant. Antigenicmolecules,normally"large"biological polymers,usuallypresentsurface featuresthatcanact as pointsof interactionforspecificantibodies.Anysuchfeature constitutesanepitope.Mostantigens have the potential tobe boundbymultiple antibodies,eachof whichisspecifictoone of the antigen's epitopes.Usingthe "lockandkey"metaphor,the antigencanbe seenasa stringof keys(epitopes) each of whichmatchesa differentlock(antibody).Differentantibodyidiotypes,eachhave distinctlyformed complementarity-determiningregions. Allergen –A substance capable of causingan allergicreaction.The (detrimental)reactionmayresult afterexposure viaingestion,inhalation,injection,orcontactwithskin. Superantigen –A class of antigensthatcause non-specificactivationof T-cells,resultinginpolyclonal T- cell activationandmassive cytokinerelease.
  • 3. Tolerogen –A substance thatinvokesaspecificimmune non-responsivenessdue toitsmolecularform. If its molecularformischanged,atolerogencanbecome animmunogen. Immunoglobulin-bindingprotein –ProteinssuchasproteinA,proteinG,and proteinLthat are capable of bindingtoantibodiesatpositionsoutside of the antigen-bindingsite.While antigensare the "target" of antibodies,immunoglobulin-bindingproteins"attack"antibodies. T-dependentantigen –Antigensthatrequirethe assistance of Tcellstoinduce the formationof specific antibodies. T-independentantigen –Antigensthatstimulate Bcellsdirectly. Immunodominantantigens –Antigensthatdominate (overall othersfromapathogen) intheirabilityto produce an immune response.Tcell responsestypicallyare directedagainstarelativelyfew immunodominantepitopes,althoughinsome cases(e.g.,infectionwiththe malariapathogen Plasmodiumspp.) itisdispersedoverarelativelylarge numberof parasite antigens.[9] Antigen-presentingcellspresentantigensinthe formof peptidesonhistocompatibilitymolecules.The T cellsselectivelyrecognize the antigens;dependingonthe antigenandthe type of the histocompatibility molecule,differenttypesof Tcellswill be activated.ForT-cell receptor(TCR) recognition,the peptide mustbe processedintosmall fragmentsinside the cell andpresentedbyamajorhistocompatibility complex (MHC).[10] The antigencannotelicitthe immuneresponse withoutthe helpof animmunologic adjuvant.[11] Similarly,the adjuvantcomponentof vaccinesplaysanessentialrole inthe activationof the innate immune system.[12][13] An immunogenisanantigensubstance (oradduct) thatisable to triggera humoral (innate) orcell- mediatedimmuneresponse.[14] Itfirstinitiatesaninnate immune response,whichthencausesthe activationof the adaptive immune response.Anantigenbindsthe highlyvariable immunoreceptor products(B-cell receptororT-cell receptor) once thesehave beengenerated.Immunogensare those antigens, termedimmunogenic,capable of inducinganimmune response.[15] At the molecularlevel,anantigencanbe characterizedbyitsabilitytobindtoan antibody'sparatopes. Differentantibodieshave the potential todiscriminateamongspecificepitopespresentonthe antigen surface.A haptenis a small moleculethatcan onlyinduce animmune responsewhenattachedtoa largercarrier molecule,suchasa protein.Antigenscanbe proteins,polysaccharides,lipids,nucleicacids or otherbiomolecules.[4] This includesparts(coats,capsules,cell walls,flagella,fimbriae,andtoxins) of bacteria,viruses,andothermicroorganisms.Non-microbial non-self antigenscaninclude pollen,egg white,andproteinsfromtransplantedtissuesandorgansor onthe surface of transfusedbloodcells. Sources Antigenscanbe classifiedaccordingtotheirsource.
  • 4. Exogenousantigens Exogenousantigensare antigensthathave enteredthe bodyfromthe outside,forexample,by inhalation,ingestionorinjection.The immunesystem'sresponsetoexogenousantigensisoften subclinical.Byendocytosisorphagocytosis,exogenousantigensare takenintothe antigen-presenting cells(APCs) andprocessedintofragments.APCsthenpresentthe fragmentstoT helpercells(CD4+) by the use of classII histocompatibilitymoleculesontheirsurface.SomeTcellsare specificforthe peptide:MHCcomplex.Theybecome activatedandstartto secrete cytokines,substancesthatactivate cytotoxicT lymphocytes(CTL),antibody-secretingBcells,macrophagesandotherparticles. Some antigensstartout as exogenousandlaterbecome endogenous(forexample,intracellularviruses). Intracellularantigenscanbe returnedtocirculationuponthe destructionof the infectedcell. Endogenousantigens Endogenousantigensare generatedwithinnormal cellsasa resultof normal cell metabolism, or because of viral or intracellularbacterial infection.The fragmentsare thenpresentedonthe cell surface inthe complex withMHCclassI molecules.If activatedcytotoxicCD8+T cellsrecognize them,the Tcells secrete varioustoxinsthatcause the lysisorapoptosisof the infectedcell.Inordertokeepthe cytotoxic cellsfromkillingcellsjustforpresentingself-proteins,the cytotoxiccells(self-reactive Tcells) are deletedasaresultof tolerance (negativeselection).Endogenousantigensinclude xenogenic (heterologous),autologousandidiotypicorallogenic(homologous) antigens.Sometimesantigensare part of the hostitself inanautoimmune disease.[2] Autoantigens An autoantigenisusuallyaself-proteinorproteincomplex(andsometimesDNA orRNA) that is recognizedbythe immune systemof patientssufferingfromaspecificautoimmune disease.Under normal conditions,theseself-proteinsshouldnotbe the targetof the immune system,butin autoimmune diseases,theirassociatedTcellsare notdeletedandinsteadattack. Neoantigens Neoantigensare those thatare entirelyabsentfromthe normal humangenome.Ascomparedwith nonmutatedself-proteins,neoantigensare of relevance totumorcontrol,asthe qualityof the T cell pool that isavailable forthese antigensisnotaffectedbycentral Tcell tolerance.Technologyto systematicallyanalyzeTcell reactivityagainstneoantigensbecame available onlyrecently.[16] Neoantigenscanbe directlydetectedandquantifiedthroughamethodcalledMANA-SRMdevelopedby a moleculardiagnosticscompany,Complete OmicsInc.,throughcollaboratingwithateaminJohns HopkinsUniversitySchool of Medicine.[17]
  • 5. Viral antigens For virus-associatedtumors,suchascervical cancerand a subsetof headand neckcancers, epitopes derivedfromviral openreadingframescontribute tothe pool of neoantigens.[16] Tumor antigens Tumor antigensare those antigens thatare presentedbyMHCclass I or MHC classII moleculesonthe surface of tumor cells.Antigensfoundonlyonsuchcellsare calledtumor-specificantigens(TSAs)and generallyresultfromatumor-specificmutation.More commonare antigensthatare presentedby tumor cellsandnormal cells,calledtumor-associatedantigens(TAAs).CytotoxicTlymphocytesthat recognize these antigensmaybe able todestroytumorcells.[16] Tumor antigenscanappearon the surface of the tumorin the formof, forexample,amutatedreceptor, inwhichcase theyare recognizedbyB cells.[16] For humantumorswithouta viral etiology,novel peptides(neo-epitopes) are createdbytumor-specific DNA alterations.[16] Process A large fractionof humantumor mutationsiseffectivelypatient-specific.Therefore,neoantigensmay alsobe basedonindividualtumorgenomes.Deep-sequencingtechnologiescanidentifymutations withinthe protein-codingpartof the genome (the exome) andpredictpotential neoantigens.Inmice models,forall novel proteinsequences,potential MHC-bindingpeptideswere predicted.The resulting setof potential neoantigenswasusedtoassessTcell reactivity.Exome–basedanalyseswere exploited ina clinical setting,toassessreactivityinpatientstreatedbyeithertumor-infiltratinglymphocyte (TIL) cell therapyorcheckpointblockade.Neoantigenidentificationwassuccessfulformultiple experimental model systemsandhumanmalignancies.[16] The false-negativerate of cancerexome sequencingislow—i.e.:the majorityof neoantigensoccur withinexonicsequence withsufficientcoverage.However,the vastmajorityof mutationswithin expressedgenesdonotproduce neoantigensthatare recognizedbyautologousTcells.[16] As of 2015 mass spectrometryresolutionisinsufficienttoexclude manyfalsepositivesfromthe pool of peptidesthatmaybe presentedbyMHC molecules.Instead,algorithmsare usedtoidentifythe most likelycandidates.Thesealgorithmsconsiderfactorssuchas the likelihoodof proteasomal processing, transportintothe endoplasmicreticulum, affinityforthe relevantMHCclassI allelesandgene expressionorproteintranslationlevels.[16]
  • 6. The majorityof human neoantigensidentifiedinunbiasedscreensdisplayahighpredictedMHCbinding affinity.Minorhistocompatibilityantigens,aconceptuallysimilarantigenclassare alsocorrectly identifiedbyMHCbindingalgorithms.Anotherpotential filterexamineswhetherthe mutationis expectedtoimprove MHCbinding.The nature of the central TCR-exposedresiduesof MHC-bound peptidesisassociatedwithpeptide immunogenicity.[16] Nativity A native antigenisanantigenthatisnot yetprocessedbyan APCto smallerparts.T cellscannotbind native antigens,butrequire thattheybe processedbyAPCs,whereasBcellscanbe activatedbynative ones. Antigenicspecificity Antigenicspecificityisthe abilityof the hostcellstorecognize anantigenspecificallyasaunique molecularentityanddistinguishitfromanotherwith exquisite precision.Antigenspecificityisdue primarilytothe side-chainconformationsof the antigen.Itismeasurable andneednotbe linearorof a rate-limitedsteporequation.[2][6] BothT cellsandB cellsare cellularcomponentsof adaptive immunity.[2][4] See also Antigenicescape Antitoxin Conformational epitope Epitope Linearepitope Magneticimmunoassay Neutralizingantibody Original antigenicsin Paul Ehrlich:Magic Bullet Polyclonal Bcell response Priming(immunology) References
  • 7. "Antibody".NationalHumanGenome ResearchInstitute,USNational Institutesof Health.2020. Retrieved13October2020. "Immune systemanddisorders".MedlinePlus,USNational Institute of Medicine.28September2020. Retrieved13October2020. Male, DavidK.(2006). Immunology.ElsevierHealthSciences.p.10.ISBN 978-0323033992. Abbas,Abul K.;Lichtman,Andrew;Pillai,Shiv(2018)."AntibodiesandAntigens".CellularandMolecular Immunology(9thed.).Philadelphia:Elsevier.ISBN 978-0-323-52324-0. Gallucci,S; Lolkema,M; Matzinger,P(November1999). "Natural adjuvants:endogenousactivatorsof dendriticcells".NatureMedicine.5(11): 1249–55. doi:10.1038/15200. PMID 10545990. S2CID 29090284. "Antigeniccharacterization".USCentersforDisease Control andPrevention.15October2019. Retrieved13October2020. Strebhardt,Klaus;Ullrich,Axel (Jun2008). "Paul Ehrlich'smagicbulletconcept:100 years of progress". Nature ReviewsCancer.8(6): 473–80. doi:10.1038/nrc2394. ISSN 1474-1768. PMID 18469827. S2CID 30063909. Lindenmann,Jean(1984)."Originof the Terms 'Antibody'and'Antigen'".Scand.J.Immunol.19(4): 281–85. doi:10.1111/j.1365-3083.1984.tb00931.x. PMID 6374880. DoolanDL, SouthwoodS,FreilichDA,SidneyJ,GraberNL,ShatneyL,BebrisL, FlorensL,DobanoC, WitneyAA,AppellaE,HoffmanSL,Yates JR,Carucci DJ, Sette A (August2003). "Identificationof Plasmodiumfalciparumantigensbyantigenicanalysisof genomicandproteomicdata".Proceedingsof the National Academyof Sciencesof the UnitedStatesof America.100 (17): 9952–57. Bibcode:2003PNAS..100.9952D. doi:10.1073/pnas.1633254100. PMC 187898. PMID 12886016. Parham,Peter.(2009). The Immune System, 3rdEdition,p.G:2, GarlandScience,TaylorandFrancis Group, LLC. Gavin,AL; Hoebe,K;Duong,B; Ota,T; Martin,C; Beutler,B;Nemazee,D(22 December2006). "Adjuvant-enhancedantibodyresponsesinthe absence of toll-like receptorsignaling".Science.314 (5807): 1936–38. Bibcode:2006Sci...314.1936G. doi:10.1126/science.1135299. PMC 1868398. PMID 17185603. JanewayCA,Jr (1 November2013). "Pillarsarticle:approachingthe asymptote?Evolutionand revolutioninimmunology.Coldspringharbsympquantbiol.1989. 54: 1–13". Journal of Immunology. 191 (9):4475–87. PMID 24141854. Gayed,PM (June 2011). "Towarda modernsynthesisof immunity:CharlesA.JanewayJr.andthe immunologist'sdirtylittle secret".The Yale Journal of BiologyandMedicine.84(2):131–38. ISSN 1551- 4056. PMC 3117407. PMID 21698045. Parham,Peter.(2009). The Immune System, 3rdEdition,p.G:11, Garland Science,TaylorandFrancis Group, LLC. KubyImmunology(6thed.).Macmillan.2006. p.77. ISBN 978-1-4292-0211-4.
  • 8. Schumacher,Ton N.;Schreiber,RobertD.(April 3,2015). "Neoantigensincancerimmunotherapy". Science.348 (6230): 69–74. Bibcode:2015Sci...348...69S. doi:10.1126/science.aaa4971. PMID 25838375. Wang, Qing.;Douglass,Jacqueline (September16,2019). "Direct DetectionandQuantificationof Neoantigens".CancerImmunol Res.7(11):1748–54. doi:10.1158/2326-6066.CIR-19-0107. PMC 6825591. PMID 31527070. vte Lymphocyticadaptive immunesystemandcomplement Lymphoid Antigens AntigenSuperantigenAllergenAntigenicvariationHapten Epitope LinearConformationalMimotope Antigenpresentation/professionalAPCs:DendriticcellMacrophageBcellImmunogen Antibodies AntibodyMonoclonal antibodiesPolyclonal antibodiesAutoantibodyMicroantibodyPolyclonal Bcell responseAllotypeIsotypeIdiotype Immune complexParatope Immunityvs. tolerance Action:ImmunityAutoimmunityAlloimmunityAllergyHypersensitivityInflammationCross-reactivityCo- stimulation Inaction:Tolerance CentralPeripheralClonal anergyClonal deletionTolerance in pregnancyImmunodeficiencyImmune privilege Immunogenetics Affinity maturationSomatichypermutationClonalselectionV(D)JrecombinationJunctional diversityImmunoglobulinclassswitchingMHC/HLA Lymphocytes CellularTcellHumoral BcellNKcell Substances CytokinesOpsoninCytolysin Authoritycontrol:National librariesEdit thisatWikidata France (data)UkraineGermanyIsraelUnitedStates
  • 9. Categories:Immune systemBiomolecules Navigationmenu Notloggedin Talk Contributions Create account Log in ArticleTalk ReadEditViewhistory Search SearchWikipedia Main page Contents Currentevents Randomarticle AboutWikipedia Contact us Donate Contribute Help Learn to edit Communityportal Recentchanges Uploadfile Tools What linkshere Relatedchanges Special pages Permanentlink
  • 10. Page information Cite thispage Wikidataitem Print/export DownloadasPDF Printable version In otherprojects WikimediaCommons Languages ‫ية‬ ‫عرب‬ ‫ال‬ Español हिन्दी Bahasa Indonesia Bahasa Melayu Português Русский ‫و‬ ‫ارد‬ 中文 59 more Editlinks Thispage waslasteditedon27 March 2022, at 06:42 (UTC). Textisavailable underthe Creative CommonsAttribution-ShareAlike License 3.0;additional termsmay apply.Byusingthissite,youagree to the Termsof Use and PrivacyPolicy.Wikipedia® isaregistered trademarkof the WikimediaFoundation,Inc.,anon-profitorganization. PrivacypolicyAboutWikipediaDisclaimersContactWikipediaMobile viewDevelopersStatisticsCookie statementWikimediaFoundationPoweredbyMediaWiki